Cardinal Health (NYSE:CAH) said today it closed its $1.2 billion sale of its Cardinal Health China business to Shanghai Pharmaceuticals. The deal covers Dublin, Ohio-based Cardinal’s pharmaceutical operations and medical distribution business in the People’s Republic, but does not include other assets there such as Cordis, the patient recovery business for which it paid Medtronic (NYSE:MDT) $6 billion or its […]
shanghaipharma
Cardinal Health to deal China biz for $1.2B
Cardinal Health (NYSE:CAH) said yesterday that it agreed to a $1.2 billion deal with Shanghai Pharmaceuticals Holding for portions of its business in China. The deal covers Dublin, Ohio-based Cardinal’s pharmaceutical operations and medical distribution business in the People’s Republic, but does not include other assets there such as Cordis, the patient recovery business for which […]